Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
APGE
APGE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
APGE News
Jefferies Recommends Low-Stress Quality Stocks Amid AI Volatility
22h ago
CNBC
iShares Core High Dividend ETF Outperforms S&P 500
1d ago
Fool
iShares Core High Dividend ETF Surges Over 15% Year-to-Date
1d ago
NASDAQ.COM
Investor Rights Law Firm Investigates Multiple Companies
1d ago
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
5d ago
PRnewswire
Analysis of XBI ETF's 52-Week Price Fluctuations
5d ago
NASDAQ.COM
Ademi LLP Investigates Apogee for Possible Violations
6d ago
Globenewswire
AbbVie Acquires Apogee to Strengthen Immunology Portfolio
Jun 30 2026
Fool
Investor Rights Law Firm Investigates Multiple Companies
Jun 25 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Jun 24 2026
Globenewswire
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
Jun 23 2026
Fool
AbbVie Acquires Apogee for $10.9 Billion to Strengthen Immunology Business
Jun 23 2026
NASDAQ.COM
Intel Shares Hit All-Time High as Market Confidence Grows
Jun 23 2026
stocktwits
Apogee Therapeutics Acquired by AbbVie at 49% Premium
Jun 23 2026
Yahoo Finance
AbbVie Acquires Apogee for Approximately $10.9 Billion
Jun 23 2026
NASDAQ.COM
AbbVie Acquires Apogee for $10.9 Billion to Enhance Immunology Portfolio
Jun 22 2026
Fool
Show More News
